SURROZEN INC (SRZN)
US86889P2083 - Common Stock
Surrozen Publishes Study in 'Respiratory Research' Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary Fibrosis
Surrozen Publishes Study in 'Respiratory Research' Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary Fibrosis...
Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043
Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043...
Surrozen Announces up to $192.5 Million Private Placement of Securities Priced At-the-Market Under Nasdaq Rules
Surrozen Announces up to $192.5 Million Private Placement of Securities Priced At-the-Market Under Nasdaq Rules ...
Surrozen Provides Corporate Update on Clinical Programs
Announces strategic prioritization of clinical programs to focus on development of SZN-043 for Alcohol-Associated Hepatitis SZN-043- Completed enrollment...
SRZN Stock Earnings: Surrozen Misses EPS for Q1 2023
SRZN stock results show that Surrozen missed analyst estimates for earnings per share the first quarter of 2023.
SRZN Stock Earnings: Surrozen Misses EPS for Q1 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Surrozen (NASDAQ:SRZN) just reported results for the first quarter of 2023.Surr...
SRZN Stock Earnings: Surrozen Beats EPS for Q2 2023
SRZN stock results show that Surrozen beat analyst estimates for earnings per share the second quarter of 2023.
SRZN Stock Earnings: Surrozen Beats EPS for Q2 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Surrozen (NASDAQ:SRZN) just reported results for the second quarter of 2023.Sur...
SRZN Stock Earnings: Surrozen Misses EPS for Q3 2023
SRZN stock results show that Surrozen missed analyst estimates for earnings per share the third quarter of 2023.
SRZN Stock Earnings: Surrozen Misses EPS for Q3 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Surrozen (NASDAQ:SRZN) just reported results for the third quarter of 2023.Surr...
Surrozen Provides Third Quarter 2023 Financial Results
Expect to announce data from SZN-043 Phase 1a clinical trial in patients with chronic liver disease and in healthy volunteers in Q1 2024 Expect to...
Surrozen Provides Second Quarter 2023 Financial Results
SZN-043 Phase 1a clinical trial in patients with chronic liver disease and in healthy volunteers continues to enroll with safety data expected by the end...
Surrozen Publishes Study in Nature Communications Demonstrating the Promise of a Fzd4 Wnt Antibody in Treating Ischemic Stroke
In a preclinical model of ischemic stroke, systemic delivery of a selective Fzd4 Wnt antibody strongly reduced blood-brain-barrier leakage, death of...
Surrozen Provides First Quarter 2023 Financial Results and Corporate and Pipeline Updates
Enrollment ongoing in SZN-043 Phase 1a clinical trial in people with chronic liver disease and in healthy volunteers with safety data expected by the end...
Surrozen Strengthens Board of Directors with the Appointment of Eric Bjerkholt
SOUTH SAN FRANCISCO, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering...
Surrozen Provides Fourth Quarter and Full Year 2022 Financial Results and Update on Clinical Pipeline and Corporate Progress
Enrolled first patient in SZN-043 Ph 1a clinical trial in chronic liver disease with data expected by the end of 2023 Expect to begin SZN-043 Ph1b...
Surrozen To Report Fourth Quarter and Full Year 2022 Financial Results and Provide a Corporate Update on March 22, 2023
SOUTH SAN FRANCISCO, Calif., March 20, 2023 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), today announced that it will...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
We're starting off Friday with an overview of the biggest pre-market stock movers traders will want to keep an eye on today!
Surrozen to Present at the 41st Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering targeted...